American Century Companies Inc Coherus Bio Sciences, Inc. Transaction History

American Century Companies Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.86 - $13.23 $211,399 - $477,272	-36,075 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$10.92 - $16.41 $424,132 - $637,364	-38,840 Reduced 51.85%	36,075 $463,000
Q4 2021 Feb 07, 2022	SELL	$15.81 - $18.99 $1,201 - $1,443	-76 Reduced 0.1%	74,915 $1.2 Million
Q3 2021 Nov 10, 2021	BUY	$12.68 - $17.79 $633,391 - $888,646	49,952 Added 199.5%	74,991 $1.21 Million
Q2 2021 Aug 05, 2021	SELL	$12.95 - $15.41 $519,295 - $617,941	-40,100 Reduced 61.56%	25,039 $346,000
Q1 2021 May 14, 2021	BUY	$14.42 - $21.39 $407,220 - $604,053	28,240 Added 76.53%	65,139 $952,000
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $371,639 - $425,051	22,442 Added 155.23%	36,899 $641,000
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $251,696 - $287,549	14,457 New	14,457 $265,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $84.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.